In 2021, BPI was served with a Form 483 letter from the FDA, alleging the company was using improper equipment and procedures and failing to vet suppliers adequately
Clinically, observational data suggest a 19% lower glaucoma incidence in GLP-1RA-treated diabetic patients than those on other antidiabetic regimens (Figure 1, this review comprehensively analyzes the mechanistic basis of GLP-1RAs in ocular diseases, synthesizes emerging clinical and preclinical evidence, and underscores their potential to redefine therapeutic strategies for vision-threatening disorders through multi-targeted disease modification
These extreme forms of altitude sickness lead to dangerous fluid buildup in the lungs and brain, respectively
This hormone helps regulate blood sugar levels, slow digestion, and promote a longer-lasting feeling of fullness after meals
Nauck MA et al
GLP-1 medications like semaglutide face scrutiny over compounded versions, raising concerns about patient safety and counterfeit products in diabetes treatment